Evidence-based clinical oncology insights

QIAGEN Clinical Insight (QCI™) is an advanced software enterprise specifically designed for production-scale, clinical-grade genomic testing laboratories. Combining the industry’s highest level of expertise and innovation, QCI Interpret provides evidence-based clinical decision support solutions, enabling you to interpret and report NGS cancer test results to your oncologists with confidence, accuracy, and clinical utility.

› Beat somatic cancer

› Fight hereditary cancer

Request a consultation
 

 

Increased NGS testing throughput

For clinical cancer testing, our platform reduces the time required to accurately interpret a patient’s test result from hours or days to less than 15 minutes per test. These efficiencies translate to sub­stantial increases in test reporting throughput by reducing turnaround time without compromising quality, comprehensiveness, or reporting standards.

› Learn about higher throughput 




Clinical labs rolling out NGS-based cancer tests are confronted with two key challenges: the complexity of turning molecular profiling information into precise medical recommendations, and the time and effort it takes to generate actionable reports. QIAGEN Clinical Insight provides a rich and detailed, yet very clear and concise, report that suggests management and treatment options based on the patient’s gene variations that profile their disease and outline causal links. It is this kind of interpretation that gives clinical value to the data, and what enables the actual insights into a patient’s specific disease and treatment options.

 

Madhuri Hegde, PhD, FACMG

Professor of Human Genetics at the Emory University School of Medicine and Executive Director of the Emory Genetics Laboratory


Get actionable cancer insights

 


© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers